Histotype
Leukemia [AML]
Parameter | Information |
---|---|
Strain | NSG |
Implant Type | Cells |
Implant Location | IV |
Time to Staging | 7 days |
Time to Evaluation Size (days) | 35.9 days |
Td | 3.0 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Human
2878